Journal of Biomedical Science,
Journal Year:
2024,
Volume and Issue:
31(1)
Published: May 30, 2024
Abstract
Severe
infection
and
sepsis
are
medical
emergencies.
High
morbidity
mortality
linked
to
CNS
dysfunction,
excessive
inflammation,
immune
compromise,
coagulopathy
multiple
organ
dysfunction.
Males
appear
have
a
higher
risk
of
than
females.
Currently,
there
few
or
no
effective
drug
therapies
protect
the
brain,
maintain
blood
brain
barrier,
resolve
inflammation
reduce
secondary
injury
in
other
vital
organs.
We
propose
major
reason
for
lack
progress
is
consequence
treat-as-you-go,
single-nodal
target
approach,
rather
more
integrated,
systems-based
approach.
A
new
revolution
required
better
understand
how
body
responds
an
infection,
identify
markers
detect
its
progression
discover
system-acting
drugs
treat
it.
In
this
review,
we
present
brief
history
followed
by
pathophysiology
from
systems’
perspective
future
opportunities.
argue
that
targeting
body’s
early
immune-driven
CNS-response
may
improve
patient
outcomes.
If
barrage
PAMPs
DAMPs
can
be
reduced
early,
CNS-organ
circuits
(or
axes)
will
preserved
reduced.
been
developing
systems-based,
small-volume,
fluid
therapy
comprising
adenosine,
lidocaine
magnesium
(ALM)
endotoxemia.
Our
studies
indicate
ALM
shifts
sympathetic
parasympathetic
dominance,
maintains
cardiovascular-endothelial
glycocalyx
coupling,
reduces
corrects
coagulopathy,
tissue
O
2
supply.
Future
research
investigate
potential
translation
humans.
Food & Function,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Autism
spectrum
disorder
(ASD)
is
a
group
of
heterogeneous
neurodevelopmental
disorders
characterized
by
social
deficits
and
repetitive
behaviors.
Increasing
evidence
suggests
that
the
gut
microbiota
influences
neurodevelopment
behavior.
In
this
study,
we
established
an
ASD
model
administering
valproic
acid
(VPA)
to
pregnant
females,
with
male
offspring
receiving
daily
synbiotic
intervention
for
four
weeks
post-weaning.
The
results
indicate
combination
2'-Fucosyllactose
(2'-FL)
Bifidobacterium
animalis
subsp.
lactis
BB-12
(BB-12)
outperformed
2'-FL
Lactobacillus
paracasei
L9300BH
(L9300BH)
in
alleviating
deficits,
behaviors,
neuronal
damage,
dysregulated
expression
social-related
genes
neuroinflammatory
markers
mice.
Additionally,
improved
morphology
barrier
integrity,
reduced
inflammation,
optimized
structure
increasing
abundance
Bifidobacteria
Akkermansia,
known
producers
short-chain
fatty
acids
(SCFAs).
Notably,
levels
acetate,
propionate,
butyrate
were
significantly
elevated
fecal
samples.
summary,
supports
homeostasis,
enhances
SCFA
levels,
mitigates
abnormalities
Small,
Journal Year:
2024,
Volume and Issue:
20(46)
Published: Aug. 7, 2024
Abstract
Wound
healing
is
a
dynamic
process
involving
the
timely
transition
of
organized
phases.
However,
infected
wounds
often
experience
prolonged
inflammation
due
to
microbial
overload.
Thus,
addressing
viable
treatment
needs
across
different
stages
critical
challenge
in
wound
management.
Herein,
novel
core‐shell
microneedle
(CSMN)
patch
designed
for
sequential
delivery
tannic
acid‐magnesium
(TA‐Mg)
complexes
and
extracellular
vesicles
from
Lactobacillus
druckerii
(LDEVs).
Upon
application
sites,
CSMN@TA‐Mg/LDEV
releases
TA‐Mg
first
counteract
pathogenic
overload
reduce
reactive
oxygen
species
(ROS),
aiding
proliferative
phase.
Subsequently,
sustained
release
LDEVs
enhances
activities
keratinocytes
fibroblasts,
promotes
vascularization,
modulates
collagen
deposition.
Notably,
track
composition
demonstrates
that
can
both
inhibit
aggressive
pathogen
increase
diversity
at
sites.
Functional
analysis
further
highlights
potential
facilitating
skin
barrier
restoration.
Moreover,
it
confirmed
accelerate
closure
improve
post‐recovery
quality
murine
wound.
Conclusively,
this
innovative
CSMN
offers
rapid
high‐quality
alternative
emphasizes
significance
homeostasis.
The Lancet Microbe,
Journal Year:
2024,
Volume and Issue:
5(8), P. 100843 - 100843
Published: April 9, 2024
The
incidence
of
antibiotic-resistant
bacterial
infections
is
increasing,
and
development
new
antibiotics
has
been
deprioritised
by
the
pharmaceutical
industry.
Interdisciplinary
research
approaches,
based
on
ecological
principles
fitness,
competition,
transmission,
could
open
avenues
to
combat
infections.
Many
facultative
pathogens
use
human
mucosal
surfaces
as
their
major
reservoirs
induce
infectious
diseases
aid
lateral
transmission
host
organisms
under
some
pathological
states
microbiome
host.
Beneficial
commensals
can
outcompete
specific
pathogens,
thereby
lowering
capacity
spread
cause
serious
Despite
clinical
relevance,
however,
understanding
commensal–pathogen
interactions
in
natural
habitats
remains
poor.
In
this
Personal
View,
we
highlight
directions
intensify
between
context
microbiomes
biology
that
lead
innovative
sustainable
ways
preventing
treating
diseases.
Cell Host & Microbe,
Journal Year:
2024,
Volume and Issue:
32(5), P. 768 - 778.e9
Published: April 22, 2024
Microbiomes
feature
complex
interactions
between
diverse
bacteria
and
bacteriophages.
Synthetic
microbiomes
offer
a
powerful
way
to
study
these
interactions;
however,
major
challenge
is
obtaining
representative
bacteriophage
population
during
the
bacterial
isolation
process.
We
demonstrate
that
colony
reliably
excludes
virulent
viruses
from
sample
sources
with
low
virion-to-bacteria
ratios
such
as
feces,
creating
"virulent
virus-free"
controls.
When
dsDNA
virome
reintroduced
73-strain
synthetic
gut
microbiome
in
bioreactor
model
of
human
colon,
target
susceptible
strains
without
significantly
altering
community
structure
or
metabolism.
In
addition,
we
detected
signals
prophage
induction
associate
predation.
Overall,
our
findings
indicate
dilution-based
methods
generate
are
heavily
depleted,
if
not
devoid,
viruses,
reintroduced,
have
targeted
effect
on
assembly,
metabolism,
replication.
Journal of Biomedical Science,
Journal Year:
2024,
Volume and Issue:
31(1)
Published: May 30, 2024
Abstract
Severe
infection
and
sepsis
are
medical
emergencies.
High
morbidity
mortality
linked
to
CNS
dysfunction,
excessive
inflammation,
immune
compromise,
coagulopathy
multiple
organ
dysfunction.
Males
appear
have
a
higher
risk
of
than
females.
Currently,
there
few
or
no
effective
drug
therapies
protect
the
brain,
maintain
blood
brain
barrier,
resolve
inflammation
reduce
secondary
injury
in
other
vital
organs.
We
propose
major
reason
for
lack
progress
is
consequence
treat-as-you-go,
single-nodal
target
approach,
rather
more
integrated,
systems-based
approach.
A
new
revolution
required
better
understand
how
body
responds
an
infection,
identify
markers
detect
its
progression
discover
system-acting
drugs
treat
it.
In
this
review,
we
present
brief
history
followed
by
pathophysiology
from
systems’
perspective
future
opportunities.
argue
that
targeting
body’s
early
immune-driven
CNS-response
may
improve
patient
outcomes.
If
barrage
PAMPs
DAMPs
can
be
reduced
early,
CNS-organ
circuits
(or
axes)
will
preserved
reduced.
been
developing
systems-based,
small-volume,
fluid
therapy
comprising
adenosine,
lidocaine
magnesium
(ALM)
endotoxemia.
Our
studies
indicate
ALM
shifts
sympathetic
parasympathetic
dominance,
maintains
cardiovascular-endothelial
glycocalyx
coupling,
reduces
corrects
coagulopathy,
tissue
O
2
supply.
Future
research
investigate
potential
translation
humans.